Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mapping Relapse Risk and Evaluating an Integrated Approach for Preventing Relapse in Polydrug Users: A Randomized Control Trial

NCT07161986 is registered in ClinicalTrials.gov with Institute of Psychology, Chinese Academy of Sciences as lead sponsor.

NCT NCT07161986
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07161986 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mapping Relapse Risk and Evaluating an Integrated Approach for Preventing Relapse in Polydrug Users: A Randomized Control Trial
Lead sponsor
Institute of Psychology, Chinese Academy of Sciences
Phase
Not applicable
Overall status
Completed
Start date
June 24, 2025
Completion date
August 24, 2025
Enrollment
130 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

drug addiction, polysubstance addiction